Trials / Conditions / Relapsed/Refractory Small Cell Lung Cancer
Relapsed/Refractory Small Cell Lung Cancer
3 registered clinical trials studyying Relapsed/Refractory Small Cell Lung Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Partici NCT07325136 | Bristol-Myers Squibb | Phase 1 / Phase 2 |
| Not Yet Recruiting | This Study is an Open-lable, Phase I Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary NCT07249879 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 1 |
| Active Not Recruiting | A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) NCT05060016 | Amgen | Phase 2 |